Beacon Gene Therapy Database Summary
- Unrivalled comprehensive & accurate preclinical and clinical Gene Therapy drug, trial and commercial data.
- Access to 2,600+ Drugs, 1,100+ Trials, 1,800+ Companies, and 1,900+ Deals in the Gene Therapy space
- Market leading ontologies, enabling precise navigation of specific Gene Therapies
- Manually curated by Gene Therapy scientists, with data updated daily
- Your one stop shop for Gene Therapy intelligence data

Why Beacon Gene Therapy Database?
How Beacon Gene Therapy Database Can Help You?
Tracking immunogenicity data across trials helps you anticipate potential immune responses to gene therapies—critical for informing vector selection, dosing strategies, and patient safety. Beacon makes it easy to compare how different approaches are managing these risks across similar indications and delivery systems.
Search the gene therapy drug & trial landscape in a unique way, with the ability to filter by propriety delivery systems such as next gen AAV vectors and access all scientific preclinical & clinical immunogenicity, toxicity & efficacy data in one place, hand curated by our gene therapy analysts.
Immunogenicity data on Beacon includes:
- Neutralizing antibodies
- Serum titres
Unparalleled access to every piece of preclinical gene therapy data in the literature, spanning conferences i.e ASGCT, publications, press releases, corporate presentations, SEC filings & company websites.
Unique manual curation with handwritten data summaries to quickly identify cell lines, animal models, preclinical dosing, & subsequent efficacy, toxicity & PK profiles for gene therapy drugs, giving you the best chance of leveraging reliable landscape data to inform your preclinical strategy.
With the level of scrutiny from investors increasing by the day, the ability to answer questions on the competitive landscape & clearly communicate your position against competitors is becoming a non-negotiable.
Beacon gene therapy has all the necessary data you need to feel confident with your investment strategy, with most comprehensive & accurate commercial data in the gene therapy market to understand areas of competition using company searching based on gene therapy technologies, identify scientific insights from company pipelines to bulletproof your investment strategy using data backed explanations & track the latest deals for gene therapies in real time.
Run gene therapy delivery-based queries in a unique way – Beacon Gene Therapy is the only database that allows you to search for proprietary technologies, with a vast number of novel of delivery systems manually tagged & indexed into categories across viral & non-viral vectors.
Efficiently dive deeper into the novel techniques & resulting data for targeted delivery, with other delivery-based searches including:
- Target organ/cell
- Route of administration
- Promoter
- Genetic material for therapy
Once identifying delivery techniques being deployed across the landscape, go a level deeper & access the most comprehensive, manually curated data on delivery including preclinical & clinical DMPK data to identify successful drugs that have managed to reach desired target tissues with minimal off target effects.
Search clinical trials in a unique way, with the ability to couple technology-based trial searches (therapeutic class delivery systems, target organ/cell, editing technology etc.) with clinical trial parameters including phase, trial status, location, indication to rapidly identify global trials of relevance to look to emulate or improve on.
Once identifying trials of importance to your own clinical strategy, access manually curated data points on clinical trial designs & readouts, such as drug dosing, patient data, toxicity readouts & clinical endpoints.
Learn more about Beacon Clinical Trial Data.
Optimize your gene therapy partnership strategy by identifying new prospect companies or competitors as soon as they enter the field, taking advantage of Beacon’s unique approach to capturing early-stage companies & depth of scientific & commercial insight captured.
Searching gene therapy companies & deals by disease, delivery systems, target organ/cell, editing technology & more provides a unique way of identifying companies based on technology overlaps & synergy with your own technology & objectives.
Support partnership outreach & diligence with curated company data by a team of gene therapy analysts, to help find the companies with best chance of commercial success to partner with.
Learn more about Beacon Company Data
Quickly narrow in on the programs that align with your business goals. Advanced filters let you search by editing technology, delivery system, promoter, gene or mutation, target organ, site of delivery, and immunogenicity—giving you the flexibility to surface insights tailored to your specific therapeutic or platform focus.
Transform Beacon data into actionable insights with the depth of data tagging allowing unique ways of visualizing the landscape, alongside access to regular landscape reviews to stay on top of the evolving landscape & predict future market growth & requirements.
Beacon Gene Therapy Database: The Numbers
Beacon Gene Therapy Database: Key Data Segments
Drug Data
Revolutionize your landscape searching for Gene Therapies
Utilize >20 search filters to find programs based on disease indication, drug modality, delivery system, editing technology, gene / mutation, and many more.
Trial Data
Optimize your Gene Therapy therapeutic clinical trial design searching capabilities.
Seamlessly benchmark clinical trial results and search the Gene Therapy trial landscape based on trial locations, trial phase, disease indication and more.
Milestones
A unique Gene Therapy development milestone filter and visualization tool.
Track past, present, and future Gene Therapy drug development milestones, including drug and trial readouts, asset history, and regulatory announcements.
Company Data
Your centralized location for Gene Therapy company intelligence
Identify competitors and business development opportunities, using unique company filters including, company type, HQ locations, operating status & latest funding round, and technologies / diseases targeted in their pipeline.
Deal Data
De-risk your Gene Therapy therapeutic partnership & fundraising projects
Search Gene Therapy deals using custom search filters based on drug technologies involved, deal value & upfront payments, deal types to filter M&As, financing & partnership / licensing deals, geographic market, funding type, and many more.
Beacon Gene Therapy: Drug Modalities
Analyze 2,600+ drugs (preclinical and clinical) and 1,100+ clinical trials (from early to late stage). Drug Modalities include:
- Gene therapies, where DNA is the genetic material for therapy or is edited, for all genetically driven non-oncology indications
- Viral & non-viral vector based therapies
- Genetically modified cell therapies
- DNA-based therapies
- CRISPR-based gene therapies
Beacon Gene Therapy also includes a host of preclinical data including, cell line and animal model experimental data.
Who is Beacon Gene Therapy Database For?
Beacon Gene Therapy is a manually curated database of comprehensive, high quality, and accurate, preclinical and clinical drug, trial and commercial data, offering unrivalled insight into the Gene Therapy drug development landscape.
Scientific Strategy Leader
Select the right pipeline for your Gene Therapy development
Research Scientist
Validate new targets & inform your Gene Therapy design
Clinical Development
Design optimized Gene Therapy clinical trials & benchmark against the competition
Business Development
Uncover new Gene Therapy licensing, partnership and fundraising opportunities
Competitive Intelligence
Track competitive threats & emerging Gene Therapy technologies
Translational Development
Confidently take your preclinical Gene Therapy into the clinic
Additional Resources
Check out Gene Therapy related resources available from Beacon
Our Experts

Victoria Marshall
Lead Research Analyst

Charlie De Lanoy Meijer
Account Manager

Frank Plowden
Account Manager
Hanson Wade Events
Check out the upcoming events from Hanson Wade